Unknown OBSERVATIONAL NCT04102319

Serum Hepcidin, Haemoglobin Level and Iron Status in Chronic Kidney Disease Patients (CKD) With Anaemia

Association Between Hepcidin, Haemoglobin Level and Iron Status in Stage 4 Chronic Kidney Disease Patients With Anaemia

Sponsor: Assiut University

Updated 5 times since 2019 Last updated: Sep 22, 2019 Started: Oct 1, 2019 Primary completion: Oct 1, 2022 Completion: Dec 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04102319, this observational or N/A phase trial focuses on CKD Stage 4 and remains ongoing. Sponsored by Assiut University, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2024 — Jul 2024 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jan 2024 [monthly]

Not Yet Recruiting
Oct 2019 — Jan 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.